Literature DB >> 23224999

In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.

Núria Benseny-Cases1, Oksana Klementieva, Josep Cladera.   

Abstract

The amyloid beta Ab(1-40) and Ab(1-42) peptides are the main components of the fibrillar plaques characteristically found in the brains affected by Alzheimer's disease. Fibril formation has been thoroughly studied in vitro using synthetic amyloid peptides and has been described to be a nucleation dependent polymerization process. During this process, defined by a slow nucleation phase followed by a rapid exponential elongation reaction, a whole range of aggregated species (low and high molecular weight aggregates) precede fibril formation. Toxic species related to the onset and development of Alzheimer's disease are thought to be found among these prefibrillar aggregates. Two main procedures are used to experimentally monitor fibril formation kinetics: through the measurement of the light scattered by the different peptide aggregates and using the fluorescent dye thioflavin T, which fluorescence increases when specifically interacting with amyloid fibrils. Reproducibility may, however, be difficult to achieve when measuring and characterizing fibril formation kinetics. This fact is mainly due to the difficulty in experimentally handling amyloid peptides, which is directly related to the difficulty of having them in a monomeric form at the beginning of the polymerization process. This has to do mainly with the type of solvent used for the preparation of the peptide stock solutions (water, DMSO, TFE, HFIP) and the control of determinant physicochemical parameters such as pH. Moreover, kinetic progression turns out to be highly dependent on the type of peptide counter-ion used, which will basically determine the duration of the nucleation phase and the rate at which high molecular weight oligomers are formed. Centrifugation and filtration procedures used in the preparation of the peptide stock solutions will also greatly influence the duration of the fibril formation process. In this chapter, a survey of the alluded experimental procedures is provided and a general frame is proposed for the interpretation of the fibril formation kinetics, intended to integrate the results from the different experimental approaches. The significance of the different aggregated species in terms of cell toxicity will be discussed. Special emphasis will be given to the influence of pH on the structural and toxic characteristics of amyloid aggregates, an aspect that may be particularly relevant in some specific physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224999     DOI: 10.1007/978-94-007-5416-4_3

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  6 in total

1.  Design, synthesis, and biological evaluation of new thalidomide-donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation.

Authors:  Cindy Juliet Cristancho Ortiz; Matheus de Freitas Silva; Letizia Pruccoli; Nathália Fonseca Nadur; Luciana Luíza de Azevedo; Arthur Eugen Kümmerle; Isabella Alvim Guedes; Laurent Emmanuel Dardenne; Luiz Felipe Leomil Coelho; Marcos J Guimarães; Fernanda M R da Silva; Newton Castro; Vanessa Silva Gontijo; Viviana C T Rojas; Merelym Ketterym de Oliveira; Fabiana Cardoso Vilela; Alexandre Giusti-Paiva; Gisele Barbosa; Lídia Moreira Lima; Gabriela Beserra Pinheiro; Letícia Germino Veras; Márcia Renata Mortari; Andrea Tarozzi; Claudio Viegas
Journal:  RSC Med Chem       Date:  2022-03-17

2.  Real-Time BODIPY-Binding Assay To Screen Inhibitors of the Early Oligomerization Process of Aβ1-42 Peptide.

Authors:  Nicolo Tonali; Veronica I Dodero; Julia Kaffy; Loreen Hericks; Sandrine Ongeri; Norbert Sewald
Journal:  Chembiochem       Date:  2020-01-09       Impact factor: 3.164

3.  Effect of alanine replacement of l17 and f19 on the aggregation and neurotoxicity of arctic-type aβ40.

Authors:  Yi-Ru Chen; Hsien-bin Huang; Chi-Jen Lo; Chih-Ching Wang; Li-Kang Ho; Hsin-Tzu Liu; Ming-Shi Shiao; Ta-Hsien Lin; Yi-Cheng Chen
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

4.  Mechanisms of U87 astrocytoma cell uptake and trafficking of monomeric versus protofibril Alzheimer's disease amyloid-β proteins.

Authors:  Yali Li; Deshu Cheng; Ran Cheng; Xinyu Zhu; Tao Wan; Jianmiao Liu; Rongying Zhang
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

5.  Neuroprotective effects of ginsenoside Rb1 on hippocampal neuronal injury and neurite outgrowth.

Authors:  Juan Liu; Jing He; Liang Huang; Ling Dou; Shuang Wu; Qionglan Yuan
Journal:  Neural Regen Res       Date:  2014-05-01       Impact factor: 5.135

6.  Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane.

Authors:  Liang Zhang; Sergey Trushin; Trace A Christensen; Utkarsh Tripathi; Courtney Hong; Rachel E Geroux; Kyle G Howell; Joseph F Poduslo; Eugenia Trushina
Journal:  Neurobiol Dis       Date:  2018-03-02       Impact factor: 5.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.